Search

Deals with the side effects of birth control pills on the skin.

Deals with the side effects of birth control pills. Chemical composition of the pills; Physiological effect of a chemical found in the pills; Comments from manufacturers of the pills.

Focuses on a study conducted by Imperial Cancer Research Fund on the long-term effect of birth control pills. Findings of the study.

The article reports on a research finding which indicates that women who have taken oral contraceptives for at least three years are twice as likely to suffer from glaucoma.

Recommends that women with classic, but not common, migraine use another form of contraception other than oral contraceptives. Possibility of increased risk of arterial thrombosis with classic migraine and oral contraceptive use.

Reports that some brands of contraceptive pills, found in Britain could double the risk of blood clots. Names of suspected brands; Reference to hormones progesterone, gestodene, desogestrel and estrogen; Details.

Reports on the low danger arising from the use of low-dose birth control pills. Increase in the risk of blood clots from all forms of birth control pills; Specifications of the low-dose pill and pills introduced under the names Desogen and Ortho-Cept; Health benefits carried by the pills.

Reports on the side effects of oral contraceptives. Water retention as common side effect.

Reports on the tragedy that befell to a bridegroom-to-be, whose fiancee died of a freak reaction to the contraceptive pill she had been taking for nine years without trouble.

Reports on the assurance made by the Family Planning Association about the safety of using oral contraceptives, following a health scare in Great Britain linking pills with increased risk of thrombosis among women.

Enumerates the brand names of contraceptive pills that could double the risk of thrombosis among women, according to Great Britain's Committee on Safety of Medicines.

Reports that women on oral contraceptives have a greater risk of developing a painful dental problem known as dry socket according to a study published in `General Dentistry.' Findings of the study; Ways of treating the dry socket.

Reports on the increase in the number of childbirths in Great Britain, a year after the British government has issued a warning concerning the side effects of certain brands of oral contraceptives. Estimates on the number of women who stopped taking the pill; Efforts of hospitals to meet the demand for maternity beds.

Focuses on estrophasic birth control pill. Side effects of some pills; How the estrophasic pill works; Doctor Leon Speroff's recommendation on how to use the estrophasic pill.

Reports that progesterones in birth control pills can make gums prone to gingivitis. Importance of keeping teeth clean for people who are on the pill.

Focuses on the cause of significant depression among people due to side-effects of hormones present in oral contraceptives. Factors responsible for depression; Need to pay attention towards the link between mental states and oral contraceptives.

Reports on the relationship between oral contraceptives and high blood pressure (B.P) in young women and their role in causing a stroke. Chances of a woman of childbearing age having a stroke, according to Albert Heyman of the Duke University Medical Center; Role of high B.P., diabetes, migraine and blood vessel diseases in increasing the chances of stroke; Chances of stroke in women with no such disease.

Reports on the increasing risk of heart attacks by the use of oral contraceptives among women in the U.S. Details of the studies analyzing the risk of heart attacks by the use of pills; Possibility of greater risk of heart attack among heavy smokers than pill users.

Examines effectiveness of various contraceptives and the development of some new contraceptives as of March 11, 1978. Side effects of oral contraceptives and intrauterine devices; Enzyme targeted by the contraceptive developed by Lourens J. Zaneveld of the University of Illinois Medical Center in Chicago, Illinois; Effectiveness of contraceptive foams and creams.

Reveals research findings indicating the absence of a long-term link between birth control pill and breast cancer. Advice for pill users to see their doctors more frequently for breast examination; Prevalence of breast cancer among women in their late forties or older.

Reports on the absence of association between taking oral contraceptives in the first trimester of pregnancy and any physical genital malformation in infants.

Reports on the normal appearance of spotting or light bleeding in between periods for women taking oral contraceptives. Possible indications if bleeding continues after three of four months of taking the pills.

Reports on reactions to studies published in 1983 in the British medical journal 'The Lancet' linking the use of oral contraceptives to breast and cervical cancer. Doubt expressed by the British Council on the Safety of Medicine regarding the role of the progestogen component of the pill in increased breast cancer risk; Criticisms of the methodology used in the breast cancer study.

Cites a report on the studies conducted by James D. Yager Junior of the New York University Medical Center in New York City on oral-contraceptive steroids which appear to be promoters of liver cancer. Suggestions from deficiency of detectable genotoxic and mutagenic effects.

The article discusses some of the side effects in taking birth control pills for other therapies, such as acne flares. Accordingly, oral contraceptives can be prescribed as nonessentials to therapies such as topical retinoids or oral isotretinoin to treat acne. However, hormonal therapy does not necessarily treat acne and it has side effects. Dr. Diane Berson of Weill Cornell Medical College states that most of the side effects are due to the estrogen compound present in the oral contraceptives.

The article offers medical news briefs. Among the mentioned topics include the study that suggests the effectiveness and safety of idarucizumab drug for reversing the effects of anticoagulant dabigatran, the association of oral contraceptives with venous thromboembolism (VTE) risk, and the adherence improvement of dabigatran drug through monitoring of dedicated pharmacist.

The article discusses the study that determined women who used oral contraceptives for more than three years to be 2.05 times more likely to suffer and be diagnosed with glaucoma, speculating a possible connection between lower estrogen levels due to birth control pills and increased glaucoma risk.

The article offers information on a research related to impact of the oral contraceptives in causing of glaucoma conducted by the researchers of three universities including the University of California, San Diego, Duke University School of Medicine and the Nanchang University in China. It noted that women who have taken oral contraceptives twice were diagnosed with glaucoma. It informs that the findings were presented at the meeting of the American Academy of Ophthalmology in November 2013.

The article discusses studies and issues related to hemostasis and thrombosis. It explores the risk and treatment for atrial fibrillation and stroke. It examines a study which determined the increased incidence rates for idiopathic venous thromboembolism (VTE) risk for women taking third-generation oral contraceptive. Another study also revealed that the interaction of cyclooxygenase-1 enzyme and aspirin can be prevented by dipyrone and some other nonsteroidal anti-inflammatory agents.

The article discusses research study on the link between new oral contraceptive formulations and risk for breast cancer in black women, by L. Rosenberg and colleagues, published in the 2010 issue of "Cancer Epidemiology Biomarkers and Prevention."

The article discusses the findings of two studies which showed the association between oral contraceptives and increased risk for venous thrombosis in Denmark and the Netherlands.

This section offers news briefs concerning asthma. A research presented at the American Academy of Allergy, Asthma & Immunology annual meeting revealed that management of asthma in children has been improved by new asthma medications and tools. A study in the March 2009 issue of "Clinical Immunology" found that respiratory inflammation related with asthma can be prevented by the intake of broccoli. A Scandinavian study showed that risk of asthma in some women is heightened by oral contraceptives.

The article discusses the history of oral contraceptives as a means of birth control. Margaret Sanger, a registered nurse, is credited with advocating contraceptives and for opening the first birth control clinic in Brooklyn. With financial help from Katharine McCormick, Gregory Pincus and John Rock, Sanger undertook clinical tests of progesterone on humans. In 1957 Enovid manufactured by G.D. Searle was approved for regulation of the menses. Adverse effects of oral contraceptives are discussed.